Vanda Pharmaceuticals Inc.
VNDA
Revenue
50.47M
▲3.01M▲6.35%
3 Months ChangeAssets
651.37M
▼-1.31M▼-0.2009%
3 Months ChangeLiabilities
108.86M
▲168.00k▲0.1546%
3 Months ChangeFree Cash Flow
7.56M
▼-24.19M▼-76.18%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-15
Form 8-K
ID: 0001193125-24-237220
2024-10-03
Form 8-K
ID: 0001193125-24-232306
2024-09-19
Form 8-K
ID: 0001193125-24-221784
2024-08-08
Form 8-K
ID: 0001193125-24-196481
2024-08-01
Form 10-Q
ID: 0001628280-24-033866
2024-07-31
Form 8-K
ID: 0001628280-24-033743
2024-06-20
Form 8-K
ID: 0001193125-24-164545
2024-06-13
Form 8-K
ID: 0001193125-24-160755
2024-06-06
Form 8-K
ID: 0001193125-24-156117
2024-05-24
Form 8-K
ID: 0001628280-24-025254